ATE513812T1 - Verfahren zur produktion von terfenadin- und carebastinderivaten mit mikroorganismen - Google Patents

Verfahren zur produktion von terfenadin- und carebastinderivaten mit mikroorganismen

Info

Publication number
ATE513812T1
ATE513812T1 AT08005953T AT08005953T ATE513812T1 AT E513812 T1 ATE513812 T1 AT E513812T1 AT 08005953 T AT08005953 T AT 08005953T AT 08005953 T AT08005953 T AT 08005953T AT E513812 T1 ATE513812 T1 AT E513812T1
Authority
AT
Austria
Prior art keywords
streptomyces
microorganism
structure according
formulae
carebastine
Prior art date
Application number
AT08005953T
Other languages
English (en)
Inventor
Peter C Michels
Eric L Zirbes
Original Assignee
Albany Molecular Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albany Molecular Res Inc filed Critical Albany Molecular Res Inc
Application granted granted Critical
Publication of ATE513812T1 publication Critical patent/ATE513812T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT08005953T 2000-11-08 2001-11-06 Verfahren zur produktion von terfenadin- und carebastinderivaten mit mikroorganismen ATE513812T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70895900A 2000-11-08 2000-11-08
US09/754,786 US6613907B2 (en) 2000-11-08 2001-01-04 Process for the production of piperidine derivatives with microorganisms

Publications (1)

Publication Number Publication Date
ATE513812T1 true ATE513812T1 (de) 2011-07-15

Family

ID=24847879

Family Applications (2)

Application Number Title Priority Date Filing Date
AT08005953T ATE513812T1 (de) 2000-11-08 2001-11-06 Verfahren zur produktion von terfenadin- und carebastinderivaten mit mikroorganismen
AT01273746T ATE419257T1 (de) 2000-11-08 2001-11-06 Verfahren zur produktion von piperidinderivaten mit mikroorganismen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT01273746T ATE419257T1 (de) 2000-11-08 2001-11-06 Verfahren zur produktion von piperidinderivaten mit mikroorganismen

Country Status (18)

Country Link
US (3) US6613907B2 (de)
EP (2) EP1339864B1 (de)
JP (3) JP4686112B2 (de)
KR (1) KR100886727B1 (de)
AT (2) ATE513812T1 (de)
BR (1) BR0115191A (de)
CA (1) CA2427387C (de)
CY (2) CY1110595T1 (de)
DE (1) DE60137255D1 (de)
DK (2) DK1339864T3 (de)
ES (2) ES2321805T3 (de)
HU (1) HU230069B1 (de)
MX (1) MXPA03004003A (de)
NO (1) NO334436B1 (de)
NZ (1) NZ526040A (de)
PT (2) PT1958935E (de)
RU (1) RU2290443C2 (de)
WO (1) WO2002083062A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6613907B2 (en) * 2000-11-08 2003-09-02 Amr Technology, Inc. Process for the production of piperidine derivatives with microorganisms
MXPA04003640A (es) * 2001-10-16 2005-04-11 Rxkinetix Inc Formulaciones de proteina de alta concentracion y metodo de fabricacion.
WO2005016912A1 (en) * 2003-08-19 2005-02-24 Pfizer Inc. An efficient microbial preparation of capravirine metabolites m4 and m5
WO2009058943A1 (en) * 2007-10-31 2009-05-07 Montana State University Gliocladium isolate c-13 and methods of its use for producing volatile compounds and hydrocarbons
US20090306135A1 (en) 2008-03-24 2009-12-10 Mukesh Kumar Sharma Stable amorphous fexofenadine hydrochloride
US8871197B2 (en) * 2010-06-03 2014-10-28 Carmel-Haifa University Economic Corporation Ltd. Extracts of Cyathus striatus mushrooms, pharmaceutical compositions comprising them and a new Cyathus striatus strain
KR101987639B1 (ko) * 2017-05-11 2019-06-12 코스맥스 주식회사 신규 후시디움 코씨네움 균주 및 그 균주 배양액을 포함하는 피부미용 개선용 조성물
GB201807815D0 (en) 2018-05-14 2018-06-27 Hypha Discovery Ltd Hydroxylation techniques
GB201819209D0 (en) * 2018-11-26 2019-01-09 Hypha Discovery Ltd Biocatalytic techniques
GB201917077D0 (en) 2019-11-22 2020-01-08 Hypha Discovery Ltd Biocatalytic techniques
US20250326720A1 (en) * 2022-05-06 2025-10-23 Chengdu Shibeikang Biomedical Technology Co., Ltd. Carebastine salt and use of same

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5A (en) * 1836-08-10 Thomas Blanchard Machine for mortising solid wooden shells of ships' tackle-blocks
US3419469A (en) * 1965-12-08 1968-12-31 Sun Oil Co Production of carboxylic acids by microbiological oxidation of hydrocarbons
GB1242169A (en) 1969-04-09 1971-08-11 Ucb Sa Piperidine derivatives
US3649453A (en) * 1970-01-21 1972-03-14 Upjohn Co Process for microbiologically oxygenating 1-amidoadamantanes
US3878217A (en) 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
BE794598A (fr) 1972-01-28 1973-05-16 Richardson Merrell Inc Nouveaux derives olefiniques de piperidines substituees en 4 et leur procede de preparation
US3965257A (en) 1972-01-28 1976-06-22 Richardson-Merrell Inc. Compositions and methods for the treatment of the symptoms of histamine induced allergic reactions
BE794596A (fr) 1972-01-28 1973-05-16 Richardson Merrell Inc Piperidinoalcanone-oximes substituees et leur procede de preparation
US3806526A (en) 1972-01-28 1974-04-23 Richardson Merrell Inc 1-aroylalkyl-4-diphenylmethyl piperidines
DE2360091A1 (de) * 1972-12-06 1974-07-04 Erap Verfahren zur herstellung von zitronensaeure durch fermentation
US3941795A (en) 1974-02-08 1976-03-02 Richardson-Merrell Inc. α-ARYL-4-SUBSTITUTED PIPERIDINOALKANOL DERIVATIVES
US3931197A (en) 1974-02-08 1976-01-06 Richardson-Merrell Inc. Substituted piperidine derivatives
US3946022A (en) 1974-03-04 1976-03-23 Richardson-Merrell Inc. Piperidine derivatives
US3922276A (en) 1974-12-11 1975-11-25 Robins Co Inc A H 1-Substituted-4-benzylidenepiperidines
US3956296A (en) 1974-12-11 1976-05-11 A. H. Robins Company, Incorporated 1-Substituted-4-benzylpiperidines
US4285957A (en) 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof
US4285958A (en) 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkylene ketones, pharmaceutical compositions thereof and method of use thereof
US4254130A (en) 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4254129A (en) 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4564594A (en) * 1983-06-30 1986-01-14 E. I. Du Pont De Nemours And Company Fermentation process for production of carboxylic acids
GB8321157D0 (en) 1983-08-05 1983-09-07 Fordonal Sa Piperidine derivatives
US4742175A (en) 1986-05-07 1988-05-03 Merrell Dow Pharmaceuticals Inc. Preparation of polymorphically pure terfenadine
NL8603073A (nl) * 1986-12-02 1988-07-01 Rijksuniversiteit Werkwijze voor het bereiden van polyesters door fermentatie; werkwijze voor het bereiden van optisch actieve carbonzuren en esters; polyester omvattende voortbrengselen.
US5032513A (en) * 1988-06-01 1991-07-16 Basf Corporation Process for the preparation of gamma and delta lactones
DE4034218A1 (de) 1990-10-27 1992-04-30 Merck Patent Gmbh Verfahren zur herstellung von carebastin
EP1688142A1 (de) 1992-08-03 2006-08-09 Sepracor Inc. Terfenadin-Carboxylat und die Behandlung von Hautreizung
GB9312669D0 (en) 1993-06-18 1993-08-04 Orion Yhtymae Oy New opticla isomers
EP1369409B1 (de) 1993-06-24 2006-04-05 AMR Technology, Inc. Verfahren zur Herstellung von Verbindungen geeignet als Zwischenprodukte
DK0705245T3 (da) 1993-06-25 2003-04-14 Merrell Pharma Inc Nye mellemprodukter til fremstilling af antihistaminiske 4-diphenylmethyl/diphenylmethoxy-piperidinforbindelser
EP0864653B1 (de) * 1997-03-11 2004-03-03 Aventis Pharmaceuticals Inc. Verfahren zur Herstellung von 4-(4-(4-(Hydroxydiphenyl)-1-piperidinyl)-1-hydroxybutyl)-alpha,alpha-dimenthylphenylessigsäure und phosphorylierter Derivate
FR2776302B1 (fr) 1998-03-19 2002-04-12 Hoechst Marion Roussel Inc Nouveau procede de preparation de la fexofenadine
US6613907B2 (en) * 2000-11-08 2003-09-02 Amr Technology, Inc. Process for the production of piperidine derivatives with microorganisms

Also Published As

Publication number Publication date
JP2008295464A (ja) 2008-12-11
WO2002083062A3 (en) 2003-01-03
BR0115191A (pt) 2004-12-14
JP2007306927A (ja) 2007-11-29
US20020087003A1 (en) 2002-07-04
MXPA03004003A (es) 2004-02-12
NZ526040A (en) 2005-10-28
PT1339864E (pt) 2009-03-26
JP4842215B2 (ja) 2011-12-21
DK1339864T3 (da) 2009-04-14
JP2004522454A (ja) 2004-07-29
HUP0301652A2 (hu) 2003-10-28
NO20031974D0 (no) 2003-04-30
ATE419257T1 (de) 2009-01-15
CA2427387C (en) 2012-01-31
JP4966276B2 (ja) 2012-07-04
WO2002083062A2 (en) 2002-10-24
RU2290443C2 (ru) 2006-12-27
DE60137255D1 (de) 2009-02-12
JP4686112B2 (ja) 2011-05-18
ES2321805T3 (es) 2009-06-12
KR20030045168A (ko) 2003-06-09
ES2395243T3 (es) 2013-02-11
RU2003117021A (ru) 2005-01-20
NO20031974L (no) 2003-06-13
HU230069B1 (hu) 2015-06-29
CY1112344T1 (el) 2015-12-09
EP1339864A2 (de) 2003-09-03
US7232908B2 (en) 2007-06-19
KR100886727B1 (ko) 2009-03-04
US7691615B2 (en) 2010-04-06
US6613907B2 (en) 2003-09-02
EP1958935A3 (de) 2008-09-03
CY1110595T1 (el) 2015-04-29
DK1958935T3 (da) 2011-10-03
PT1958935E (pt) 2011-08-17
EP1958935B1 (de) 2011-06-22
NO334436B1 (no) 2014-03-03
US20050038254A1 (en) 2005-02-17
US20070134774A1 (en) 2007-06-14
CA2427387A1 (en) 2002-10-24
EP1958935A2 (de) 2008-08-20
HUP0301652A3 (en) 2012-09-28
EP1339864A4 (de) 2005-01-12
EP1339864B1 (de) 2008-12-31

Similar Documents

Publication Publication Date Title
CY1112344T1 (el) Μεθοδος για την παραγωγη παραγωγων τερφεναδινης και καρεβαστινης με μικροοργανισμους
ATE121091T1 (de) Phospholipase a2-inhibitor, mikroorganismen, die diesen inhibitor erzeugen und mehrere verfahren zu seiner herstellung.
WO2000047758A3 (en) Methods of making compounds
DK499186A (da) Mikrobielt fremstillet cellulose, fremgangsmaade til fremstilling af samme samt mikroorganisme til anvendelse ved fremgangsmaaden
US4474881A (en) Process for preparing polyprenyl carboxylic acid derivatives
JP2769194B2 (ja) 酵素分解方法
EP0421636A1 (de) Verfahren zur enzymatischen Auflösung
ATE338140T1 (de) Fructosyl-transferase produzierender mikroorganismus und verfahren zur herstellung von fructooligosacchariden und neofructooligosacchariden unter dessen verwendung
US5182198A (en) Process for preparing (+)-homopilopic acid
DK0589285T3 (da) Fremgangsmåde til fremstilling af biotin
EP0997534A3 (de) Verfahren zur Racematspaltung von Arylalkylcarbonsäureestern
WO2002095044A2 (en) Lipase catalyzed esterification, transesterification, and hydrolysis of arylthiols and aryl-thioesters
ATE356214T1 (de) Mikrobiologisches verfahren zur herstellung von l-carnitin
AU2001282002A1 (en) Method for the enantioselective reduction of 8-chloro-6-oxo-octanoic acid alkyl esters
KR890003955A (ko) 광학 활성 인-함유 작용성 아세트산 유도체의 효소적 제조방밥
AU4264799A (en) Method for stereoselective production of substituted cyclohexylcyanhydrins
KR900000481A (ko) 3-메르캡토-2-알킬-프로피온산의 라세미 에스테르 유도체들의 광학 이성질체의 효소 분리방법
ATE389026T1 (de) Verfahren für die herstellung von inhibitoren der hmg-coa-reduktase.
US5420037A (en) Process for separation of enantiomeric 3-mercapto-2-substituted alkanoic acid using lipase P30 and synthesis of captopril type compounds
DE69214891D1 (de) Verfahren zur enzymatischen Herstellung von 7-Amino-Cephalosporansäure
US5128263A (en) Enzymatic resolution process hydrolyzing thio-ester
BR0100789A (pt) Processo microbiano para a preparação de derivados de 3-hidroxipirrolidina opticamente ativos
AU4188800A (en) Pseudomycin production by (pseudomonas syringae)
EP0148272A1 (de) Verfahren zur herstellung optisch aktiven benzylalkohols
WO2002022849A3 (en) Enzymatic resolution of aryl- and thio-substituted acids

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1958935

Country of ref document: EP